Clinical trial

Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBC

NCT07103447

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-09-10

PhasePHASE2

Study timeline

Study start (estimated)2025-09-10Date precision: day

Registry last updated2025-08-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer - Femaleunresolved

Interventions

AK112, Carboplatin, PaxlitaxelDRUG

Sponsors & collaborators

Shuangyue Liulead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07103447 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.